TLDR
Market Recap: February 10, 2026
On February 10, Indian equities extended gains for a third straight session as renewed FPI buying and upbeat global cues kept risk appetite firm, while earnings momentum drove stock-specific moves. Sensex closed at 84,273.92, up 208.17 (+0.25%); Nifty 50 ended at 25,935.15, up 67.85 (+0.26%). Broader markets stayed constructive with Nifty Midcap 100 at 60,723.00 (up 281.85, +0.47%) and Nifty Smallcap 100 at 17,451.20 (up 65.30, +0.38%). Volatility eased as India VIX fell to 11.67 (down about 4.3%), signalling higher comfort despite a busy results tape.
Key Drivers :
FPI bid stabilises sentiment: Provisional data showed FPIs net bought on Feb 9, reinforcing early Feb inflow momentum after three months of selling.
Sector rotation stayed pro-risk: Autos led (about +1.4%), and metals added (about +0.8%) as traders leaned into cyclicals with breadth improving.
Global cues supportive, vol cooled: Asia remained positive, and Japan hit record highs; the India VIX slipping below 12 added confidence to add beta.
Today’s Top Stories:
Eicher Motors: Q3 beat on Royal Enfield demand; capex to expand capacity signals confidence in premium 2W runway.
Samvardhana Motherson: Profit and revenue accelerated; stock jumped as investors leaned into tailwinds from electronics and wiring content.
BSE: Profit nearly tripled on transaction leverage; fresh highs suggest the market is paying up for volume durability.
Edelweiss: Profit doubled, and Carlyle entry boosted narrative; sharp rally reflects a re-rating bid on fee businesses.
Pfizer India: Solid growth print with visible one-offs; shares popped as investors priced execution over noise.
TOP STORIES
1. Eicher beats cleanly, Royal Enfield demand stays hot
Gemini-2.5
Print: Q3 profit rose to ₹1,421 cr; revenue jumped to ₹6,114 cr on strong domestic sales.
So what: Board cleared ₹958 cr capex to scale capacity to 2.0 mn units by FY28.
Tape: Stock held firm as the market stayed bullish on premium 2W momentum.
Eicher beat estimates and signaled capacity confidence. Your take?
2. Motherson delivers double-digit growth, auto upcycle stays intact
Gemini-2.5
Print: Q3 profit +16.5% to ₹1,024 cr; revenue +14% to ₹31,409 cr on strong demand.
So what: Higher content areas like wiring and electronics are driving stickier value per vehicle.
Tape: Shares popped up to 6% as the print reinforced execution confidence.
Motherson printed strong growth and rallied. What drives the next leg?
3. BSE profit nearly triples, transaction leverage shows up
Gemini-2.5
Print: Q3 profit surged 174% to ₹602 cr; revenue grew 62% to ₹1,244 cr.
So what: Operating leverage is kicking in as trading activity scales, especially in derivatives.
Tape: Stock hit fresh highs with a strong momentum bid on earnings.
$BSE.NSE ( ▲ 6.23% )
BSE profit surged on transaction leverage. Your view?
4. Edelweiss doubles profit, Carlyle entry upgrades the narrative
Gemini-2.5
Print: Q3 profit +112% to ₹264 cr; recoveries and fee businesses supported the quarter.
So what: Carlyle’s ₹2,100 cr stake adds validation and growth optionality in alternatives and ARC.
Tape: Shares surged about 10% as the market priced both earnings and partnership upside.
Edelweiss profit doubled and Carlyle came in. How do you read it?
5. Pfizer India prints strong growth, one-offs flagged but ignored
Gemini-2.5
Print: Q3 profit +11% to ₹141.8 cr; revenue +20% to ₹645 cr, with ₹58.2 cr exceptional items.
So what: Cipla tie-up plus restructuring noise matters, but the focus stays on core momentum.
Tape: Stock jumped about 9% as investors looked through the one-off charges.
Pfizer posted a strong quarter but flagged one-offs. Your stance?
GYAANI HOT TAKES
Disclaimer:
The IndiaStox Research Hackathon is intended for educational and community engagement purposes only. Submissions do not constitute investment advice, nor should they be construed as recommendations to buy or sell any securities.
By participating in the IndiaStox Research Hackathon and submitting content, you grant IndiaStox a worldwide, royalty-free, perpetual, and irrevocable license to use, reproduce, modify, publish, distribute, and display your submission, whether in whole or in part, across its digital platforms and in promotional materials. This license extends to both commercial and non-commercial purposes, including content seeding, editorial use, and advertising.
By submitting your work, you confirm that it is your original creation and that you have the right to grant the above license.
